| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | JCI | Ordinary Shares | Options Exercise | $7.67M | +205K | +16.28% | $37.36 | 1.47M | Feb 6, 2025 | Direct | |
| transaction | JCI | Ordinary Shares | Sale | -$14M | -163K | -11.13% | $85.99 | 1.3M | Feb 6, 2025 | Direct | F1 |
| transaction | JCI | Ordinary Shares | Sale | -$3.66M | -42.1K | -3.23% | $86.89 | 1.26M | Feb 6, 2025 | Direct | F2 |
| transaction | JCI | Ordinary Shares | Options Exercise | $4.92M | +132K | +10.45% | $37.36 | 1.39M | Feb 7, 2025 | Direct | |
| transaction | JCI | Ordinary Shares | Options Exercise | $2.45M | +73.5K | +5.28% | $33.39 | 1.47M | Feb 7, 2025 | Direct | |
| transaction | JCI | Ordinary Shares | Sale | -$17.6M | -200K | -13.66% | $88.02 | 1.27M | Feb 7, 2025 | Direct | F3 |
| transaction | JCI | Ordinary Shares | Sale | -$433K | -4.89K | -0.39% | $88.57 | 1.26M | Feb 7, 2025 | Direct | F4 |
| holding | JCI | Ordinary Shares | 108K | Feb 6, 2025 | GRO Sr. 5 Year GRAT | ||||||
| holding | JCI | Ordinary Shares | 69.9K | Feb 6, 2025 | Oliver Family Trust (SLAT) |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | JCI | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -205K | -60.9% | $0.00 | 132K | Feb 6, 2025 | Ordinary Shares | 205K | $37.36 | Direct | F5 |
| transaction | JCI | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -132K | -100% | $0.00 | 0 | Feb 7, 2025 | Ordinary Shares | 132K | $37.36 | Direct | F5 |
| transaction | JCI | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -73.5K | -17.2% | $0.00 | 354K | Feb 7, 2025 | Ordinary Shares | 73.5K | $33.39 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.66 to $86.63 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F2 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $86.66 to $87.17 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $87.50 to $88.49 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F4 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $88.50 to $88.67 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F5 | Subject to certain acceleration and forfeiture provisions, fifty percent of the options become exercisable on the second anniversary of the grant and the remaining fifty percent become exercisable on the third anniversary of the grant. |